UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation

Clinical hematology international, 2022-09, Vol.4 (3), p.89-98

2022

Volltextzugriff (PDF)

Chimeric antigen receptor T‐cell therapy: Challenges and framework of outpatient administration

EJHaem, 2022-01, Vol.3 (Suppl 1), p.54-60

2022

Volltextzugriff (PDF)

Clinical outcomes of early defibrotide discontinuation: a single-center case series

Bone marrow transplantation (Basingstoke), 2024-02, Vol.59 (2), p.285-287

2024

Volltextzugriff (PDF)

The Essentials of Drug Interactions in Hematopoietic Stem Cell Transplantation

Clinical hematology international, 2019-06, Vol.1 (2), p.124-126

2019

Volltextzugriff (PDF)

Evaluation of healthcare-associated infection rates in patients with hematologic malignancies and stem cell transplantation during the coronavirus disease 2019 (COVID-19) pandemic

Antimicrobial stewardship & healthcare epidemiology : ASHE, 2022-01, Vol.2 (1), p.e11-e11, Article e11

2022

Volltextzugriff (PDF)

Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study

Blood advances, 2018-08, Vol.2 (16), p.2127-2135

2018

Volltextzugriff (PDF)

Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Journal of managed care & specialty pharmacy, 2020-02, Vol.26 (2), p.186-196

2020

Volltextzugriff (PDF)

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide

EJHaem, 2020-11, Vol.1 (2), p.576-580

2020

Volltextzugriff (PDF)

Maintenance Strategies After Hematopoietic Cell Transplantation

Pharmacotherapy, 2020-08, Vol.40 (8), p.727-740

2020

Volltextzugriff (PDF)

Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia

Journal of oncology pharmacy practice, 2023-09, Vol.29 (6), p.1326-1333

2023

Volltextzugriff (PDF)

Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study

Biology of blood and marrow transplantation, 2018-07, Vol.24 (7), p.1406-1414

2018

Volltextzugriff (PDF)

Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study

Bone marrow transplantation (Basingstoke), 2020-01, Vol.55 (1), p.224-232

2020

Volltextzugriff (PDF)

Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study

Annals of hematology, 2020-05, Vol.99 (5), p.1137-1139

2020

Volltextzugriff (PDF)

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program

Biology of blood and marrow transplantation, 2018-10, Vol.24 (10), p.2081-2087

2018

Volltextzugriff (PDF)

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia

Bone marrow transplantation (Basingstoke), 2018-06, Vol.53 (6), p.795-799

2018

Volltextzugriff (PDF)

American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States

Biology of blood and marrow transplantation, 2019-01, Vol.25 (1), p.26-33

2019

Volltextzugriff (PDF)

Impact of adherence to pomalidomide on medication adherence in pre-existing chronic conditions in patients with multiple myeloma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e20010-e20010

2018

Volltextzugriff (PDF)

Adherence to pomalidomide in patients with multiple myeloma: A US-based claims study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e20008-e20008

2018

Volltextzugriff (PDF)

Impact of Initiating Oral Anticancer Agent Therapy for Chronic Myelogenous Leukemia Among Adults with Multiple Chronic Conditions

Blood, 2022-11, Vol.140 (Supplement 1), p.11016-11017

2022

Volltextzugriff (PDF)

Impact of Initiating Oral Anticancer Agent Therapy for Chronic Lymphocytic Leukemia Among Adults with Multiple Chronic Conditions

Blood, 2022-11, Vol.140 (Supplement 1), p.10951-10952

2022

Volltextzugriff (PDF)

Clinical Outcomes of Early Defibrotide Discontinuation: A Single-Center Case Series

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S458-S459

2024

Volltextzugriff (PDF)

Changes in chronic disease medication adherence following oral anticancer agent initiation in patients with multiple myeloma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18760-e18760

2021

Volltextzugriff (PDF)

Primary care oncology model (PCOM): Implementation of a model integrating primary and oncology care for patients taking oral anticancer agents

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS1587-TPS1587

2021

Volltextzugriff (PDF)

Multicenter Retrospective Evaluation of Treatment of High-Risk Acute Promyelocytic Leukemia (APL): Results from the Hematology Research Outcomes (HERO) Consortium

Blood, 2023-11, Vol.142 (Supplement 1), p.4267-4267

2023

Volltextzugriff (PDF)

Impact of oral oncolytic initiation on medication adherence for pre-existing comorbid chronic conditions

Journal of oncology pharmacy practice, 2020-06, Vol.26 (4), p.835-845

2020

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(70)
Buchkapitel
(5)

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation

Chimeric antigen receptor T‐cell therapy: Challenges and framework of outpatient administration

Clinical outcomes of early defibrotide discontinuation: a single-center case series

The Essentials of Drug Interactions in Hematopoietic Stem Cell Transplantation

Evaluation of healthcare-associated infection rates in patients with hematologic malignancies and stem cell transplantation during the coronavirus disease 2019 (COVID-19) pandemic

Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study

Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide

Maintenance Strategies After Hematopoietic Cell Transplantation

Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia

Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study

Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study

Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia

American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States

Impact of adherence to pomalidomide on medication adherence in pre-existing chronic conditions in patients with multiple myeloma

Adherence to pomalidomide in patients with multiple myeloma: A US-based claims study

Impact of Initiating Oral Anticancer Agent Therapy for Chronic Myelogenous Leukemia Among Adults with Multiple Chronic Conditions

Impact of Initiating Oral Anticancer Agent Therapy for Chronic Lymphocytic Leukemia Among Adults with Multiple Chronic Conditions

Clinical Outcomes of Early Defibrotide Discontinuation: A Single-Center Case Series

Changes in chronic disease medication adherence following oral anticancer agent initiation in patients with multiple myeloma

Primary care oncology model (PCOM): Implementation of a model integrating primary and oncology care for patients taking oral anticancer agents

Multicenter Retrospective Evaluation of Treatment of High-Risk Acute Promyelocytic Leukemia (APL): Results from the Hematology Research Outcomes (HERO) Consortium

Impact of oral oncolytic initiation on medication adherence for pre-existing comorbid chronic conditions

Suchergebnisse filtern